Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,098 public trials 1,201 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0137 Duarte, California, United States
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
View all 67 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (RCC), Carcinoma, +14 more
Locations
  • Local Institution - 0178 Palo Alto, California, United States
  • Local Institution - 0117 New Haven, Connecticut, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Local Institution - 0177 Miami, Florida, United States
View all 96 locations
View Trial Details
Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

NCT05482516

Conditions
Adenocarcinoma, Adenocarcinoma of Biliary Tract, Carcinoma, +24 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
Locations
  • City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 185 locations
View Trial Details

Related conditions